Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Amryt Pharma

Explore full profile

Develops and delivers treatments for patients with rare and orphan diseases.

Dublin, IrelandFounded 2004Biotech & Life Sciences
Valuation $1.25B Market cap · 2026
Revenue $265M Latest reported FY
EBITDA $68M Latest reported FY

At a glance

Status
Listed
Founded
2004
Headquarters
Dublin, Ireland
Listing
IPO 2012
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later6 investors entered at this stage

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
14 countries with
team presence
🇮🇪 Ireland55.6%
🇺🇸 United States12.6%
🇮🇱 Israel4.7%
🇨🇴 Colombia4.7%
🇸🇦 Saudi Arabia4.7%
Top 5 of 14 shown
Web traffic by country
590 monthly visits
across markets
🇯🇵 Japan50.8%
🇮🇳 India16.9%
🇭🇷 Croatia16.9%
🇦🇷 Argentina16.9%
Top 4 markets shown

Patents

Estimated portfolio value
$125M

37 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Amryt Pharma was the backer or acquirer, 2016–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across Amryt Pharma's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Amryt Pharma deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Amryt Pharma's portfolio, mapped.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Amryt Pharma on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Amryt Pharma on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles